Pregabalin Retard 165 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pregabalin Retard 165 mg, covering 2026-04-02 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Low-dose Pregabalin Retard (82.5 mg) Versus Standard-dose Pregabalin Retard (165 mg) on Postoperative Pain and Opioid Consumption After Elective Laparoscopic Abdominal Surgery [NA]